ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Acepodia Biotech, Inc.
Acepodia Biotech, Inc.
SCG Cell Therapy Pte. Ltd.
Brooklyn ImmunoTherapeutics, LLC
Fate Therapeutics
Fate Therapeutics
Corregene Biotechnology Co., Ltd
Brooklyn ImmunoTherapeutics, LLC